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ABSTRACT
INTRODUCTION: Until now, there has been no routinely measured laboratory marker, which indicates 
acute inflammation from viral origin. According to some authors, the serum amyloid A (SAA) protein is of 
great importance in such circumstances. 
AIM: The aim of this article is to establish the clinical significance of SAA as a potential laboratory marker 
for viral infections. 
MATERIALS AND METHODS: Sera samples from 93 subjects with different viral infections, including 
influenza (n=31), infectious mononucleosis (n=31), and chickenpox (n=31) were analyzed. Levels of SAA 
were prospectively measured by immunoturbidimetry, adapted on Olympus AU 400. Thirty healthy subjects 
were included in the control group. 
RESULTS: In comparison with the control group, the levels of SAA were significantly higher, reaching a 
mean concentration of up to 180.80±199.87 mg/L. During convalescence, the levels decreased dramatically 
achieving a level of up to 31.29±83.42 mg/L. The highest concentrations were registered in the cases 
with different complications, such as secondary bacterial infections. In comparison with erythrocyte 
sedimentation rate (ESR), C-reactive protein (CRP), and leukocytes, SAA levels were statistically significant 
for minor inflammatory stimuli, such as viral infections are. 
CONCLUSION: SAA increases significantly in the course of different viral infections, such as influenza, 
infectious mononucleosis, and chickenpox. Early normalization of its levels correlates with full recovery, 
lack of complications and auspicious prognosis of the disease.
Keywords: serum amyloid A, virus, inflammation, 
acute phase response, immune
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controls; 2) in comparison with leukocytes, CRP, and 
ESR; 3) in the relationship with the severity of the 
disease and present complications. 
MATERIALS AND METHODS
The study group consisted of 93 patients ad-
mitted to the Department of Infectious Diseases, St. 
Marina University Hospital, Varna, Bulgaria with an 
acute onset of influenza (n=31), chickenpox (n=31), 
and infectious mononucleosis (n=31). The control 
group consisted of 30 healthy subjects. The including 
criteria are shown on Table 1. Etiologic diagnosis was 
made by ELISA assay, proving the specific IgM anti-
bodies blood circulation. Two serum samples of 5 mL 
were obtained by the Vacutainer System from all sub-
jects—on the day of admission, and 4.97±1.35 days 
later. Blood was centrifuged at 3500x g for 10 min by 
HERAEUS, Kendro, Germany centrifuge. Sera sam-
ples were stored at −20°C until analyzed. SAA and 
CRP were measured by immunoturbidimetric as-
says, adapted on Olympus AU400, AU400 Chemis-
try Analyzer. New automatic technology, Roller20PN, 
ALIFAX, for measuring of ESR was used. Reference 
ranges for all markers are shown on Table 2.  ANOVA 
test and post hoc analysis were used for comparison 
INTRODUCTION
Changes in the different laboratory markers, 
which appear in the course of many infectious dis-
eases, have a great importance for establishing the 
correct diagnosis, as well as for the developed com-
plications and outcome of the disease (1). Nowa-
days, routinely measured are leukocytes, C-reactive 
protein (CRP), and erythrocyte sedimentation rate 
(ERS), which par excellence indicate bacterial infec-
tions, but they also react during many autoimmune 
disorders and neoplastic diseases (2). Viruses induce 
a weak synthesis of the mentioned markers. Until 
now, a laboratory indicator for a virus-caused disease 
has not existed. Some authors declare that the serum 
amyloid A (SAA) protein may be useful because its 
serum concentrations increase 1000 fold in the acute 
phase of infectious mononucleosis, measles, chicken-
pox, herpes zoster, hepatitis, and influenza (3,4). 
AIM
The aim of this article is to study SAA as a di-
agnostic marker for virus-caused inflammation. For 
the achievement of that aim, we analyzed changes in 
the sera concentrations of SAA in the course of some 
acute viral infections: 1) in comparison with healthy 
Analyzed Group Control Group
1-60 years of age 1-60 years of age
Acute onset of influenza, chickenpox, and infectious 
mononucleosis, incl. severe and complicated forms 
Healthy persons without signs and symptoms of any 
infectious disease  
Lack of chronic non-infectious diseases, such as hyper-
tonia, chronic obstructive pulmonary disease, diabetes 
mellitus, etc. 
People without chronic diseases 
Vaccination done more than 30 day before the onset of 
the disease 
Vaccination done more than 30 day before present blood 
analysis 
Signed informed consent form Signed informed consent form 
Table 1. Inclusion criteria for the subjects from the analyzed and the control group





Children up to 14 years of age: 2-34 mm/h
Adults up to 50 years of age: men: 2-28 mm/h; women: 2-37 mm/h 
Adults over 50 years of age: men: 2-37 mm/h; women: 2-39 mm/h
Adults over 70 years of age: 3-46 mm/h  
Table 2. Reference ranges of analyzed laboratory markers
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between SAA and other studied markers for inflam-
mation. Paired t-test was used for analyzing the role 
of SAA as a marker for severe and complicated form 
of infection. A p-value <0.005 was considered statis-
tically significant.
RESULTS AND DISCUSSION
Ninety-three patients were analyzed in the 
present study. Two subgroups were formed: non-se-
vere (n=62, or 66.67%) and severe, complicated (n=31, 
or 33.33%). On the day of admission, 81 (87.10%) pa-
tients’ sera reacted with higher than normal SAA 
concentrations with rapid decline during the con-
valescent stage (see Table 3). This fact indicates that 
SAA may be used as a potential laboratory marker for 
acute onset of viral infections, and also, it has an ear-
ly prognostic value about the outcome of the disease. 
However, 34 (36.56%) patients’ sera samples 
stayed abnormal even throughout the convalescence. 
We think that this phenomenon results from a lack 
of full recovery at the time when the second sam-
ple was obtained. It suggests SAA could be a useful 
marker about the grade of recovery and it respective-
ly determines the optimal duration of the initiated 
treatment.
The same results have been registered by Miwa-
ta et al. in 1993 (5) and Yueru et al.  in 2017 (6), who 
have found that the levels of SAA were higher in the 
viral infection group than those in healthy controls 
and concluded that normal concentrations of SAA in 
the second sample correlated with the full recovery 
of the patients. 
In addition to SAA, the levels of CRP, ESR, and 
leukocytes were determined in all subjects (see Ta-
ble 4). SAA showed a greater incremental change in 
the acute phase, with concentrations ranging from 
0.8 to 1041.0 mg/L when compared with CRP (0.17-
402.87 mg/L), ESR (4-120 mm/h), and leukocytes 
(2.25-31.26x109/L). High SAA concentrations were 
observed despite normal CRP, ESR, and leukocytes 
count in 24 (25.81%), 40 (43.01%), and 57 (61.29%) 
subjects, respectively. It is known that the mentioned 
three laboratory markers do not react (or they re-
act within narrow limits) in the course of a viral in-
flammation. So, our results are similar to those pub-
lished by some authors, who indicate SAA is a sensi-
tive acute phase protein, which increases during mi-
nor inflammatory stimuli induced by different vi-
ruses (7,8,9).
Table 5 shows all the complications we regis-
tered in our patients. 
Analyzing the severe, complicated group (31 
subjects), we found that changes only in SAA concen-
trations were statistically significant to report a pres-
ent complication (W=4.89, p=0.021). Such character-
istic was mostly related with the cases of infectious 
mononucleosis and chickenpox, where p<0.028. So, 
on the basis of the post hoc analysis (see Table 6), we 
did not find significant differences for ESR and CRP 











Acute 259.20±223.43 168.92±229.34 123.28±146.83
3.08±1.93
Convalescent 24.33±33.47 52.11±174.87 17.44±41.94
Table 3. Mean concentrations of SAA (mg/L) in the acute and convalescent stages of the illness
Stage of Illness Diagnosis ESR CRP Leukocytes 
Acute
Influenza 34.48±24.17 43.34±89.66 7.21±3.45
Chickenpox 33.42±24.88 20.33±22.63 7.74±3.56
Infectious mononucleosis 42.77±24.06 48.70±52.94 11.62±5.17
Convalescent 
Influenza 29.81±22.98 16.71±40.80 6.49±2.69
Chickenpox 29.59±18.79 3.46±4.28 6.87±2.33
Infectious mononucleosis 31.35±21.17 5.02±8.49 8.62±2.91
Table 4. Mean concentrations of ESR, CRP, and leukocytes in the acute and convalescent stages of the illness
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es, which is opposite to the literature data about the 
great potential of CRP as a laboratory marker for sec-
ondary bacterial infections (10,11).
CONCLUSION
In conclusion, we establish that SAA may be 
used as a sensitive laboratory marker for early diag-
nosis of different viral infections. It is more sensitive 
than CRP, ESR, and leukocytes. Also, its rapid de-
crease indicates convalescent stage, which indirect-
ly correlates with the optimal duration of the treat-
ment and early and exact prognosis about the dis-
ease outcome. Compared with other acute phase pro-
teins, SAA is more sensitive as a marker for present 
complications, especially in the course of infectious 
mononucleosis and chickenpox. So, we recommend 
routine measurement of SAA in the clinical practice 
of medical doctors who work with patients suffering 
from viral infections. 
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Complications Numbers %
Acute bronchitis 13 41.9
Acute laryngitis 2 6.5
Acute tonsillitis 2 6.5
Acute pyelonephritis 1 3.2
Pneumonia 3 9.7
Herpes simplex labialis 1 3.2
Mixed infection with rotavirus 2 6.5
Acute hepatic involvement 5 16.1
Furunculosis 1 3.2
Nephrotic syndrome 1 3.2
Total 31 100.0






















Table 6. ANOVA test
